drugset / Trial / NCT05364164
A Food Effect Study of CT-L01 After Oral Administration in Healthy Volunteers
RandomizedCrossoverOpen-labelTreatment
Summary
This is a phase 1, randomized, open-label, single-dose, crossover, single-center study to evaluate food effect on the pharmacokinetics and safety of CT-L01 after oral administration in healthy volunteers.
Timeline
- Start
- 2022-07-09
- Primary completion
- 2022-07-19
- Completion
- 2022-07-25
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Alogliptin | Unknown | 12.5 mg | Oral |
| Subject | Metformin | Small molecule | 1000 mg | Oral |
Indications
No indication recorded.